Myriad Genetics | MYGN - Market Capitalization


Myriad Genetics reported $514.1M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Becton, Dickinson and Co. USD 61.93B 13.17B Nov/2026
Bio-Rad Laboratories USD 8.71B 840M Nov/2026
Bruker USD 9.68B 181M Nov/2026
Danaher USD 157.81B 18.96B Sep/2026
Illumina USD 37.12B 3.64B Nov/2026
J&J USD 653.61B 42.25B Sep/2026
Mettler Toledo International USD 36.07B 5.79B Nov/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 25.72B 2.26B Sep/2026
Quidel USD 942M 192M Nov/2026
Repligen USD 9.74B 1.1B Nov/2026
Revvity USD 19.52B 2.61B Nov/2026
Standard Biotools USD 227M 95M Nov/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
Veracyte USD 4.12B 414M Nov/2026
Waters USD 27.52B 14.26B Nov/2026